| Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. | |
| | |
MedLine Citation:
|
PMID: 21377275 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The use of medications to treat substance use disorders (SUDs) has emerged as a potentially central part of the treatment armamentarium. In this paper we present data from several recent US national surveys showing that despite the clinical promise of these medications, there has been limited adoption of pharmacotherapies in the treatment of SUDs. The data reveal variable patterns of use of disulfiram, buprenorphine, tablet naltrexone, acamprosate and injectable naltrexone. After examining the environmental and institutional context for the adoption of pharmacotherapies, the specific organizational facilitators and barriers of medication adoption are considered. The paper concludes with a discussion of the minimal clinical and administrative guidance available to enhance adoption, the lack of client and consumer knowledge of medications that puts a brake on their adoption and availability, and the difficulties that must be surmounted in bringing new medications to market. |
| | |
Authors:
|
Paul M Roman; Amanda J Abraham; Hannah K Knudsen |
Related Documents
:
|
21335815 - Development of a customizable software application for medical imaging analysis and vis... 14524385 - Biology, ecology, and prevalence of dust mites. 16378875 - Odyssey between the constellations and neuromedicine. 11270545 - Retrosigmoid approach to acoustic neuroma (vestibular schwannoma). 10311345 - Drgs are not the answer. 15607285 - Characteristics of alcohol-related fatal general aviation crashes. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-01-27 |
Journal Detail:
|
Title: Addictive behaviors Volume: 36 ISSN: 1873-6327 ISO Abbreviation: Addict Behav Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-04-04 Completed Date: 2011-09-13 Revised Date: 2012-02-09 |
Medline Journal Info:
|
Nlm Unique ID: 7603486 Medline TA: Addict Behav Country: England |
Other Details:
|
Languages: eng Pagination: 584-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Center for Research on Behavioral Health and Human Services Delivery, Institute for Behavioral Research, University of Georgia, Athens GA 30602, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Alcohol Deterrents
/
therapeutic use* Buprenorphine / therapeutic use Disulfiram / therapeutic use Humans Naltrexone / therapeutic use Narcotic Antagonists / therapeutic use* Patient Education as Topic Substance Abuse Treatment Centers / organization & administration, statistics & numerical data Substance-Related Disorders / drug therapy* Taurine / analogs & derivatives, therapeutic use United States |
| Grant Support | |
ID/Acronym/Agency:
|
R01 DA013110-12/DA/NIDA NIH HHS; R01 DA014482-10/DA/NIDA NIH HHS; R01AA015974/AA/NIAAA NIH HHS; R01DA13110/DA/NIDA NIH HHS; R01DA14482/DA/NIDA NIH HHS; R37 DA013110-12/DA/NIDA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Alcohol Deterrents; 0/Narcotic Antagonists; 107-35-7/Taurine; 16590-41-3/Naltrexone; 52485-79-7/Buprenorphine; 77337-76-9/acamprosate; 97-77-8/Disulfiram |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing acti...
Next Document: Do neurotrophins regulate the feto-placental development?